Transcat, Inc. (TRNS – Q3FY20) – Transcat posts decent growth in Q3, remains positive on 2020 outlook.

in , on April 17, 2020

Transcat announced that it has acquired substantially all of the assets of TTE Laboratories, Inc. TTE, founded in 1989 and based in Boston, MA, is a provider of broad range of pipette services, from ISO 17025 and 8655 compliant calibration to repair, refurbishment or replacement, calibration management and user training. TTE has approximately $8 million in annual revenue, roughly split 60/40 between calibration service sales and product sales. TTE serves the life sciences market, including biotech and pharmaceutical, as well as R&D labs and universities.

Executive Summary

 Financial Statements

– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Results Overview
– Company Overview
– Geographic Performance
– Segment Performance
– Guidance
– Conclusion

Historical Performance

– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– DuPont Analysis
– ROIC
– P/E Band
– Per Share Data

Product Performance and Key Developments

– Ownership
– Competitors
– Key Developments

Valuation and Consensus Performance

– Consensus view and analyst trend on stock
– Analyst Recommendations

 Market Price Performance

Release Information

  • Released
    :

    April 17, 2020

  • Last Updated
    :

    April 17, 2020